X. Zhang et al. / Tetrahedron 69 (2013) 1553e1558
1557
3.259 mmol) in dry Et2O. The resulting mixture was allowed to
general procedure as a colorless oil. 1H NMR (400 MHz, CDCl3)
d:
warm to room temperature and stirred for 1.5 h. The reaction was
quenched by the careful addition of satd Na2S2O3 solution, and the
resulting mixture was filtered through a Celite pad and the aqueous
layer was extracted with DCM (3ꢂ20 mL), and the combined or-
ganic phase was washed with brine, dried over Na2SO4, and con-
centrated under vacuum. The crude was purified by FC (silica gel,
hexanes/EtOAc 5:1) to give compound 7 as a colorless oil (148 mg,
5.95 (s, 1H), 5.75 (dt, J¼6.4, J¼11.2, 1H), 5.54 (dt, J¼7.6, J¼10.8, 1H),
4.21 (d, J¼6.4, 2H), 2.97 (d, J¼7.6, 2H), 1.84 (s, 3H); 13C NMR
(100 MHz, CDCl3) d 145.9, 130.8, 128.5, 75.9, 58.4, 37.1, 24.1; IR (film,
cmꢀ1): 3336, 2920, 2850, 1028, 766, 666; EI-HRMS calcd for
C7H11IO, 237.9855; found: 237.9860 ([M]þ).
4.2.2. tert-Butyl-(2Z,5E)-6-iodo-5-methylhexa-2,5-dienyloxy)dime-
thylsilane (11). Compound 11 was prepared in 91% yield after puri-
fication according to the general procedure as a light yellow oil. 1H
65%). 1H NMR (400 MHz, CDCl3)
d: 6.26 (s, 1H), 4.28 (s, 2H), 3.10 (d,
J¼1.6, 2H), 1.90 (s, 3H), 1.66 (br s, 1H); 13C NMR (100 MHz, CDCl3)
d
141.7, 81.9, 81.6, 77.2, 51.3, 28.6, 23.8; IR (film, cmꢀ1): 2289, 2213,
NMR (400 MHz, CDCl3)
d
: 5.93 (s, 1H), 5.66 (dt, J¼6.0, J¼11.2, 1H),
1668, 1627, 1271, 1012; EI-HRMS calcd for C7H9IO, 235.9698; found:
5.42 (dt, J¼7.6, J¼11.2,1H), 4.22 (d, J¼6.0, 2H), 2.93 (d, J¼7.2, 2H),1.83
235.9701 ([M]þ).
(s, 3H), 0.90 (s, 9H), 0.07 (s, 6H); 13C NMR (100 MHz, CDCl3)
d
146.0,
132.0, 126.4, 75.7, 59.2, 37.3, 25.9, 24.1, 18.3, ꢀ5.2; IR (film, cmꢀ1):
2954, 2929, 2856, 1661, 1254, 1101, 776, 667; HRMS (EI) peaks and
HRMS (ESIþ) peaks due to [MþH]þ or [MþNa]þ were not detected.
4.1.3. (E)-6-Bromo-1-iodo-2-methylhex-1-en-4-yne (5). To a solu-
tion of 7 (39 mg, 0.165 mmol) and CBr4 (72 mg, 0.215 mmol) in dry
DCM (2 mL) at 0 ꢁC under N2 protection, was added PPh3 (65 mg,
0.248 mmol) portionwise. After 15 min, the solution was warmed to
room temperature and stirred for another 1 h. The solvent was
removed in vacuum and the crude was purified by FC (silica gel,
hexanes) to give compound 5 as a light yellow oil (43 mg, 89%). 1H
4.2.3. (2Z,5E)-6-Iodo-5-methylhexa-2,5-dienyl benzoate (13).
Compound 13 was prepared in 73% yield (recovered 20% SM)
after purification according to the general procedure as a pale
yellow oil. 1H NMR (400 MHz, CDCl3)
d: 8.05e8.03 (m, 2H),
NMR (400 MHz, CDCl3)
d
: 6.26 (s, 1H), 3.93 (t, J¼2.4, 2H), 3.12 (d,
7.58e7.52 (m, 1H), 7.46e7.42 (m, 2H), 6.00 (s, 1H), 5.83 (dt, J¼6.8,
J¼1.6, 2H),1.90 (s, 3H); 13C NMR (100 MHz, CDCl3)
d 141.4, 83.4, 77.5,
J¼11.2, 1H), 5.42 (dt, J¼7.6, J¼10.8, 1H), 4.87 (d, J¼6.8, 2H), 3.07
77.2, 28.7, 23.8, 14.9; IR (film, cmꢀ1): 2233, 1632, 1208, 1130, 611,
(d, J¼7.6, 2H), 1.87 (s, 3H); 13C NMR (100 MHz, CDCl3)
d 166.4,
565; EI-HRMS calcd for C7H8BrI, 297.8854; found: 297.8859 ([M]þ).
145.5, 133.0, 131.1, 130.1, 129.6, 128.4, 125.9, 76.2, 60.3, 37.3, 24.1;
IR (film, cmꢀ1): 2923, 1717, 1601, 1584, 1451, 768, 711; HRMS (EI)
peaks and HRMS (ESIþ) peaks due to [MþH]þ or [MþNa]þ were
not detected.
4.1.4. (2R,5S)-2-tert-Butyl-5-((E)-6-iodo-5-methylhex-5-en-2-ynyl)-
5-methyl-1,3-dioxolan-4-one (8). To a solution of diisopropylamine
(44 mg, 0.430 mmol) in THF (1 mL) at ꢀ60 ꢁC was added n-BuLi
(0.173 mL, 0.415 mmol, 2.4 M in hexanes) dropwise. The solution
was warmed to ꢀ10 ꢁC over 1 h and then recooled to ꢀ90 ꢁC. Next,
a solution of dioxolanone 4 (66 mg, 0.415 mmol) in THF (1 mL) was
added slowly down the walls of the flask for precooling. The re-
action mixture was stirred at ꢀ90 ꢁC for 10 min and then the
bromide 5 (40 mg, 0.134 mmol) was added dropwise. The reaction
mixture was warmed slowly to ꢀ10 ꢁC over 2 h and then quenched
with satd aqueous NH4Cl (1 mL). The aqueous layer was extracted
with EtOAc (3ꢂ20 mL), and the combined organic phase was
washed with brine, dried over Na2SO4, and concentrated under
4.2.4. (E)-1-Iodo-2-methylpenta-1,4-dien-3-ol (15). Compound 15
was prepared in 73% yield after purification according to the gen-
eral procedure as a pale yellow oil. 1H NMR (400 MHz, CDCl3)
d:
6.40 (s, 1H), 5.86e5.78 (m, 1H), 5.35e5.21 (m, 2H), 4.67 (d, J¼5.6,
1H), 1.81 (s, 3H); 13C NMR (100 MHz, CDCl3)
d 148.1, 137.8, 116.5,
78.9, 78.2, 20.3; IR (film, cmꢀ1): 3398, 2955, 2918, 1462, 1377; EI-
HRMS calcd for C6H9IO, 223.9698; found: 223.9701 ([M]þ).
4.2.5. 2-Iodopenta-1,4-dien-3-ol (17). Compound 17 was prepared
in 81% yield after purification according to the general procedure as
vacuum. The crude was purified by FC (silica gel, hexanes/EtOAc
a colorless oil. 1H NMR (400 MHz, CDCl3)
d: 6.45e6.44 (m, 1H), 5.92
20
20:1) to give compound 8 as a pale yellow oil (42 mg, 85%). [
a
]
(d, J¼1.6, 1H), 5.84 (ddd, J¼5.2, J¼10.4, J¼15.6, 1H), 5.42 (dt, J¼1.2,
D
ꢀ10.2 (c 1.2, CHCl3); 1H NMR (400 MHz, CDCl3)
d: 6.25 (s, 1H), 5.37
17.2, 1H), 5.33 (dt, J¼1.2, 10.4, 1H), 4.37 (s, 1H), 1.56 (br s, 1H); 13C
(s, 1H), 3.03 (s, 2H), 2.70e2.57 (m, 2H), 1.89 (s, 3H), 1.48 (s, 3H),
NMR (100 MHz, CDCl3) d 137.5, 125.9, 117.5, 115.7, 78.5; IR (film,
0.96(s, 9H); 13C NMR (100 MHz, CDCl3)
d
174.5, 142.0, 109.5, 79.4,
cmꢀ1): 3405, 3081, 2924, 2854, 1640, 1631, 1082, 1038, 990, 910;
HRMS (EI) peaks and HRMS (ESIþ) peaks due to [MþH]þ or
[MþNa]þ were not detected.
79.0, 77.2, 77.1, 34.6, 28.7, 27.8, 23.7, 23.3, 23.1; IR (film, cmꢀ1):
2964, 2218, 1799, 1694, 1632, 1485, 1175, 1146, 1077, 983; EI-HRMS
calcd for C15H21IO3, 376.0535; found: 376.0540 ([M]þ).
4.2.6. (E)-8-Iodo-7-methylocta-1,7-dien-4-yn-3-ol (19). Compound
19 was prepared in 75% yield (recovered 25% SM) after purification
according to the general procedure as a colorless oil. 1H NMR
4.2. General experimental procedure for the partial
hydrogenation
(400 MHz, CDCl3)
d
: 6.25 (s, 1H), 5.97 (ddd, J¼5.2, 10.0, 15.2, 1H),
To a solution of nickel acetate tetrahydrate (72 mg, 0.289 mmol)
in EtOH (2 mL) was added a solution of sodium borohydride (11 mg,
0.289 mmol) in EtOH (0.5 mL) quickly. The solution was stirred for
5.44 (d, J¼17.2, 1H), 5.22 (d, J¼10.4, 1H), 4.89 (dd, J¼1.2, 3.6, 1H),
3.12 (s, 2H), 1.90 (s, 3H); 13C NMR (100 MHz, CDCl3)
d 141.6, 137.2,
116.4, 82.5, 82.2, 77.2, 63.4, 28.6, 23.8; IR (film, cmꢀ1): 3359, 3065,
2914, 2878, 2247, 2210, 1643, 1416, 1378, 928; EI-HRMS calcd for
C9H11IO, 261.9855; found: 261.9858 ([M]þ).
30 min and then added ethylenediamine (7.5 mL, 0.115 mmol) fol-
lowed by addition of alkyne (0.096 mmol) dissolved in EtOH
(0.2 mL). The reaction mixture was stirred under 1 atm of hydrogen
for a few minutes (2e5 min) and then removed the hydrogen tube.
The reaction was monitored by TLC. Upon transformation of the
starting material, water was added. The mixture was extracted with
EtOAc, and the combined organic phase was washed with brine,
dried over Na2SO4, and concentrated under vacuum. The crude was
purified by FC (silica gel) to give the designed product.
4.2.7. (4Z,7E)-8-Iodo-7-methylocta-1,4,7-trien-3-ol (20). Compound
20 was prepared in 83% yield after purification according to the
general procedure as a colorless oil. 1H NMR (400 MHz, CDCl3)
d:
5.96 (s, 1H), 5.89 (ddd, J¼6.0, 10.4, 16.8, 1H), 5.58e5.49 (m, 2H), 5.26
(d, J¼17.6,1H), 5.14 (d, J¼10.4, 1H), 4.94e4.93 (m,1H), 3.00 (d, J¼6.0,
2H), 1.85 (s, 3H); 13C NMR (100 MHz, CDCl3)
d 145.7, 139.2, 132.7,
128.1, 115.1, 76.1, 68.9, 37.3, 24.1; IR (film, cmꢀ1): 3364, 3066, 2964,
2878, 1642, 1619, 987, 926, 765, 669; EI-HRMS calcd for C9H13IO,
264.0011; found: 263.9898 ([M]þ).
4.2.1. (2Z,5E)-6-Iodo-5-methylhexa-2,5-dien-1-ol (9). Compound 9
was prepared in 77% yield after purification according to the